Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

DGAP-News: Medios AG adopts sustainability strategy and plans climate neutrality by 2023
DGAP-News: Medios AG adopts sustainability strategy and plans climate neutrality by 2023
DGAP-News: Medios AG adopts sustainability strategy and plans climate neutrality by 2023
DGAP-News: Medios AG: Kartellfreigabe für die geplante Übernahme der NewCo Pharma Gruppe
DGAP-News: Medios AG: Kartellfreigabe für die geplante Übernahme der NewCo Pharma Gruppe
DGAP-News: Medios AG: Kartellfreigabe für die geplante Übernahme der NewCo Pharma Gruppe
DGAP-News: Medios AG: Planned takeover of NewCo Pharma Group approved by Cartel Office
DGAP-News: Medios AG: Planned takeover of NewCo Pharma Group approved by Cartel Office
DGAP-News: Medios AG: Planned takeover of NewCo Pharma Group approved by Cartel Office
DGAP-Adhoc: HelloFresh SE legt indikative Prognose für das Geschäftsjahr 2022 vor
DGAP-Adhoc: HelloFresh SE legt indikative Prognose für das Geschäftsjahr 2022 vor
DGAP-Adhoc: HelloFresh SE legt indikative Prognose für das Geschäftsjahr 2022 vor
DGAP-Adhoc: HelloFresh SE provides indicative outlook for full year 2022
DGAP-Adhoc: HelloFresh SE provides indicative outlook for full year 2022
DGAP-Adhoc: HelloFresh SE provides indicative outlook for full year 2022
DGAP-Adhoc: Medios AG successfully completes capital increase with gross proceeds of approximately €72 m and placement of an upsize option
DGAP-Adhoc: Medios AG successfully completes capital increase with gross proceeds of approximately €72 m and placement of an upsize option
DGAP-Adhoc: Medios AG successfully completes capital increase with gross proceeds of approximately €72 m and placement of an upsize option
DGAP-Adhoc: Medios AG schließt Barkapitalerhöhung mit einem Bruttoemissionserlös von rund 72 Mio. € sowie Platzierung einer Upsize-Option in vollem Umfang erfolgreich ab
DGAP-Adhoc: Medios AG schließt Barkapitalerhöhung mit einem Bruttoemissionserlös von rund 72 Mio. € sowie Platzierung einer Upsize-Option in vollem Umfang erfolgreich ab
DGAP-Adhoc: Medios AG schließt Barkapitalerhöhung mit einem Bruttoemissionserlös von rund 72 Mio. € sowie Platzierung einer Upsize-Option in vollem Umfang erfolgreich ab
DGAP-Adhoc: Medios AG beschließt Barkapitalerhöhung im Umfang von bis zu 10 % des Grundkapitals
DGAP-Adhoc: Medios AG beschließt Barkapitalerhöhung im Umfang von bis zu 10 % des Grundkapitals
DGAP-Adhoc: Medios AG beschließt Barkapitalerhöhung im Umfang von bis zu 10 % des Grundkapitals
DGAP-Adhoc: Medios AG resolves on capital increase against cash contributions of up to 10% of the share capital
DGAP-Adhoc: Medios AG resolves on capital increase against cash contributions of up to 10% of the share capital
DGAP-Adhoc: Medios AG resolves on capital increase against cash contributions of up to 10% of the share capital
DGAP-News: Medios baut mit Kauf der NewCo Pharma Gruppe seine Marktposition im Bereich Herstellung deutlich aus und erschließt neue Wachstumspotentiale
DGAP-News: Medios baut mit Kauf der NewCo Pharma Gruppe seine Marktposition im Bereich Herstellung deutlich aus und erschließt neue Wachstumspotentiale
DGAP-News: Medios baut mit Kauf der NewCo Pharma Gruppe seine Marktposition im Bereich Herstellung deutlich aus und erschließt neue Wachstumspotentiale
DGAP-News: Medios significantly expands its market position in manufacturing with the acquisition of NewCo Pharma Group and taps new growth potentials
DGAP-News: Medios significantly expands its market position in manufacturing with the acquisition of NewCo Pharma Group and taps new growth potentials
DGAP-News: Medios significantly expands its market position in manufacturing with the acquisition of NewCo Pharma Group and taps new growth potentials
DGAP-Adhoc: Medios erwirbt NewCo Pharma Gruppe
DGAP-Adhoc: Medios erwirbt NewCo Pharma Gruppe
DGAP-Adhoc: Medios erwirbt NewCo Pharma Gruppe
DGAP-Adhoc: Medios acquires NewCo Pharma Group
DGAP-Adhoc: Medios acquires NewCo Pharma Group
DGAP-Adhoc: Medios acquires NewCo Pharma Group
2 Uranium Stocks Fueling Growth From the Nuclear Power Surge: https://www.marketbeat.com/logos/articles/med_20241001150849_2-uranium-stocks-fueling-growth-from-the-nuclear-p.jpg
2 Uranium Stocks Fueling Growth From the Nuclear Power Surge

Uranium stocks have been surging thanks to the Constellation Energy Co. (NASDAQ: CEG) and Microsoft Co. (NASDAQ: MSFT) deal for the largest power-purchasing deal in history. The large hyperscalers

2 Uranium Stocks Fueling Growth From the Nuclear Power Surge: https://www.marketbeat.com/logos/articles/med_20241001150849_2-uranium-stocks-fueling-growth-from-the-nuclear-p.jpg
2 Uranium Stocks Fueling Growth From the Nuclear Power Surge

Uranium stocks have been surging thanks to the Constellation Energy Co. (NASDAQ: CEG) and Microsoft Co. (NASDAQ: MSFT) deal for the largest power-purchasing deal in history. The large hyperscalers

Wake Up to This Biotech Stock That Still Has Big Potential Upside: https://www.marketbeat.com/logos/articles/med_20240927080630_wake-up-to-this-biotech-stock-that-still-has-big-p.jpg
Wake Up to This Biotech Stock That Still Has Big Potential Upside

Centessa Pharmaceuticals (NASDAQ: CNTA) is a biotechnology stock that has nearly doubled its value so far this year, and its run may not be over. Analysts at Morgan Stanley have just massively

Wake Up to This Biotech Stock That Still Has Big Potential Upside: https://www.marketbeat.com/logos/articles/med_20240927080630_wake-up-to-this-biotech-stock-that-still-has-big-p.jpg
Wake Up to This Biotech Stock That Still Has Big Potential Upside

Centessa Pharmaceuticals (NASDAQ: CNTA) is a biotechnology stock that has nearly doubled its value so far this year, and its run may not be over. Analysts at Morgan Stanley have just massively

3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI: https://www.marketbeat.com/logos/articles/med_20240923103335_3-uranium-stocks-to-gain-as-microsoft-goes-nuclear.jpg
3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI

Microsoft Co. (NASDAQ: MSFT) signed a 20-year power purchase agreement with Constellation Energy Co. (NASDAQ: CEG). The clean electricity will come from a revived nuclear reactor formerly known as

3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI: https://www.marketbeat.com/logos/articles/med_20240923103335_3-uranium-stocks-to-gain-as-microsoft-goes-nuclear.jpg
3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI

Microsoft Co. (NASDAQ: MSFT) signed a 20-year power purchase agreement with Constellation Energy Co. (NASDAQ: CEG). The clean electricity will come from a revived nuclear reactor formerly known as

Maximize Dividend Growth and Market Cap With These 3 Stock Picks: https://www.marketbeat.com/logos/articles/med_20240923090545_maximize-dividend-growth-and-market-cap-with-these.jpg
Maximize Dividend Growth and Market Cap With These 3 Stock Picks

Now that the market is shifting due to the new path the Federal Reserve (the Fed) has undertaken recently, cutting interest rates and starting a new monetary policy easing cycle, investors need to

A Tale of Two Titans: Unveiling the Value in Baidu and JD.com: https://www.marketbeat.com/logos/articles/med_20240912082553_a-tale-of-two-titans-unveiling-the-value-in-baidu.jpg
A Tale of Two Titans: Unveiling the Value in Baidu and JD.com

The past few years have been turbulent for Chinese companies listed on U.S. exchanges. Their stock prices have floundered despite major U.S. indexes reaching new heights. This disconnect is

A Tale of Two Titans: Unveiling the Value in Baidu and JD.com: https://www.marketbeat.com/logos/articles/med_20240912082553_a-tale-of-two-titans-unveiling-the-value-in-baidu.jpg
A Tale of Two Titans: Unveiling the Value in Baidu and JD.com

The past few years have been turbulent for Chinese companies listed on U.S. exchanges. Their stock prices have floundered despite major U.S. indexes reaching new heights. This disconnect is

Baidu's Strong Quarter Proves a Smart Pick for Michael Burry: https://www.marketbeat.com/logos/articles/med_20240823082705_baidus-strong-quarter-proves-a-smart-pick-for-mich.jpg
Baidu's Strong Quarter Proves a Smart Pick for Michael Burry

Recently, investors have had the chance to gain insight into the portfolios of Wall Street’s mega investors, from Warren Buffett and his multi-billion dollar positions and portfolio shifts to

Baidu's Strong Quarter Proves a Smart Pick for Michael Burry: https://www.marketbeat.com/logos/articles/med_20240823082705_baidus-strong-quarter-proves-a-smart-pick-for-mich.jpg
Baidu's Strong Quarter Proves a Smart Pick for Michael Burry

Recently, investors have had the chance to gain insight into the portfolios of Wall Street’s mega investors, from Warren Buffett and his multi-billion dollar positions and portfolio shifts to

3 Promising Small-Cap AI Stocks for the Next Market Rally: https://www.marketbeat.com/logos/articles/med_20240806140126_chart-vrnt-862024.png
3 Promising Small-Cap AI Stocks for the Next Market Rally

A bubble burst in AI, aiding weakness in the broad market, but it is not the end of an era rather than the first of many bubbles yet to form. AI is an emergent technology; the first wave of